metoprolol has been researched along with Osteoporosis, Postmenopausal in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zang, Y | 1 |
| Tan, Q | 1 |
| Ma, X | 1 |
| Zhao, X | 1 |
| Lei, W | 1 |
1 other study available for metoprolol and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Osteogenic actions of metoprolol in an ovariectomized rat model of menopause.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bone Density; Disease Models, Animal; Female; Human | 2016 |